190 related articles for article (PubMed ID: 9624152)
1. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket.
Gum RJ; McLaughlin MM; Kumar S; Wang Z; Bower MJ; Lee JC; Adams JL; Livi GP; Goldsmith EJ; Young PR
J Biol Chem; 1998 Jun; 273(25):15605-10. PubMed ID: 9624152
[TBL] [Abstract][Full Text] [Related]
2. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution.
Eyers PA; Craxton M; Morrice N; Cohen P; Goedert M
Chem Biol; 1998 Jun; 5(6):321-8. PubMed ID: 9653550
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
[TBL] [Abstract][Full Text] [Related]
4. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.
Young PR; McLaughlin MM; Kumar S; Kassis S; Doyle ML; McNulty D; Gallagher TF; Fisher S; McDonnell PC; Carr SA; Huddleston MJ; Seibel G; Porter TG; Livi GP; Adams JL; Lee JC
J Biol Chem; 1997 May; 272(18):12116-21. PubMed ID: 9115281
[TBL] [Abstract][Full Text] [Related]
5. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases.
Goedert M; Cuenda A; Craxton M; Jakes R; Cohen P
EMBO J; 1997 Jun; 16(12):3563-71. PubMed ID: 9218798
[TBL] [Abstract][Full Text] [Related]
6. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles.
Kumar S; McDonnell PC; Gum RJ; Hand AT; Lee JC; Young PR
Biochem Biophys Res Commun; 1997 Jun; 235(3):533-8. PubMed ID: 9207191
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of inhibitor selectivity in MAP kinases.
Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
[TBL] [Abstract][Full Text] [Related]
8. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket.
Tong L; Pav S; White DM; Rogers S; Crane KM; Cywin CL; Brown ML; Pargellis CA
Nat Struct Biol; 1997 Apr; 4(4):311-6. PubMed ID: 9095200
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for p38 protein kinase inhibitor specificity.
Lisnock J; Tebben A; Frantz B; O'Neill EA; Croft G; O'Keefe SJ; Li B; Hacker C; de Laszlo S; Smith A; Libby B; Liverton N; Hermes J; LoGrasso P
Biochemistry; 1998 Nov; 37(47):16573-81. PubMed ID: 9843424
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
Simon C; Goepfert H; Boyd D
Cancer Res; 1998 Mar; 58(6):1135-9. PubMed ID: 9515796
[TBL] [Abstract][Full Text] [Related]
11. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase.
Wilson KP; McCaffrey PG; Hsiao K; Pazhanisamy S; Galullo V; Bemis GW; Fitzgibbon MJ; Caron PR; Murcko MA; Su MS
Chem Biol; 1997 Jun; 4(6):423-31. PubMed ID: 9224565
[TBL] [Abstract][Full Text] [Related]
12. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580.
Eyers PA; van den IJssel P; Quinlan RA; Goedert M; Cohen P
FEBS Lett; 1999 May; 451(2):191-6. PubMed ID: 10371163
[TBL] [Abstract][Full Text] [Related]
13. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta.
Knebel A; Morrice N; Cohen P
EMBO J; 2001 Aug; 20(16):4360-9. PubMed ID: 11500363
[TBL] [Abstract][Full Text] [Related]
14. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding.
Frantz B; Klatt T; Pang M; Parsons J; Rolando A; Williams H; Tocci MJ; O'Keefe SJ; O'Neill EA
Biochemistry; 1998 Sep; 37(39):13846-53. PubMed ID: 9753474
[TBL] [Abstract][Full Text] [Related]
15. Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways.
Knebel A; Haydon CE; Morrice N; Cohen P
Biochem J; 2002 Oct; 367(Pt 2):525-32. PubMed ID: 12171600
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38.
Westermarck J; Holmström T; Ahonen M; Eriksson JE; Kähäri VM
Matrix Biol; 1998 Dec; 17(8-9):547-57. PubMed ID: 9923649
[TBL] [Abstract][Full Text] [Related]
17. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes.
Dean JL; Brook M; Clark AR; Saklatvala J
J Biol Chem; 1999 Jan; 274(1):264-9. PubMed ID: 9867839
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p38 MAP kinase increases okadaic acid mediated AP-1 expression and DNA binding but has no effect on TRE dependent transcription.
Rosenberger SF; Gupta A; Bowden GT
Oncogene; 1999 Jun; 18(24):3626-32. PubMed ID: 10380884
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils.
Waterman WH; Molski TF; Huang CK; Adams JL; Sha'afi RI
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):17-20. PubMed ID: 8870643
[TBL] [Abstract][Full Text] [Related]
20. Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis.
Callsen D; Brüne B
Biochemistry; 1999 Feb; 38(8):2279-86. PubMed ID: 10029520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
